CDC does the right thing, reverses course on testing after widespread criticism of its tweaking a month ago. Those who have been exposed to an infected person (again) urged to get tested (NBC News)
U.S. Postal Service planned to deliver face masks directly to households. The Trump administration blocked it (Complex)
Poorly protected postal workers are catching COVID-19. More than 50,000 workers have taken time off for virus-related reasons, slowing mail delivery and threatening the integrity of the election (ProPublica)
Two new studies show that coronavirus can spread during airplane travel. The extent of in-flight transmission is not yet known. One of the studies, published in the CDC journal Emerging Infectious Diseases, used genetic analysis to confirm in-flight transmission involving 4 people (CNN Health)
New study shows rates of COVID-19 deaths are higher in counties with increased level of hazardous air pollutants, even controlling on socioeconomic status, and average ozone and air-borne particles (Environmental Research Letters)
Daily U.S. COVID-19 cases rebound last week. Numbers rising in 45 of 51 states, possibly foreshadowing arrival of cold/flu season U.S. daily cases are ping-ponging heading into the last week of September making it hard to know where the U.S. epidemic is headed (See Figure B). After dipping to just 22,000 on September 8, daily numbers have been resurgent, now above 40,000 for three days. I am trying hard not to over-interpret the surge in cases over the past week. The data have been growing less consistent in recent months. However, I see one feature of the data presently that has me pretty nervous. Figure C shows the 7-day growth factors in cases by state. That, as usual, is the ratio of total new cases in the last 7 days compared to the prior week. Values higher than 1 mean cases are growing. Last time I showed you this figure on September 8 (included as Figure D for comparison), new cases were on the decline in all U.S. regions and in 33 of 51 states (plus DC). However, in Figure C, the numbers are >1.0 in 45 of 51 places. That is a worrisome turnaround. New cases are rising in all regions, but especially in the West where we see some impressive jumps last week. Arizona, which had been on the decline recently, leads the way with more than 5,400 new cases last week, which more than doubled from the 2,600 the week before. California now has over 774,000 total cases, which is more than 10% of the U.S. total and puts that state 5# in the world ahead of Columbia (765,000) and behind Russia (1.1 million). Thankfully, new cases grew just 3% last week, but that still was 23,800 new infections. New weekly cases grew by more than 50% in Colorado (+80%), Montana (+63%), Utah (+88%), Wyoming (+62%) and Wisconsin (+64%), the only Midwest state growing at that pace. The bottom line: the U.S. outbreak remains inscrutable, cases are on the upswing broadly in many states. I worry it is possible we are starting to see the leading edge of cold and flu season as we brace for overlapping outbreaks of respiratory illness.
Deaths holding steady, approach 200,000. Big picture, there is good news and bad depending on your perspective Thursday, Friday and Saturday saw deaths fall in the U.S. below 1,000 a day. However, the number of American lives lost continues to mount as we near the 200,000 threshold. If I had told you in March that more than 200,000 American’s will die before October 1, would you have believed it? Actually, I did but that is another story. This week I found myself stepping back from the day-to-day numbers for a look at the epidemic curve of COVID-19 mortality since the beginning. I prepared two additional figures for this purpose to illustrate a key issue that arises in looking at epidemiologic data. First, let’s look at Figure F, showing a plot of cumulative deaths in the U.S. since the very first recorded death on February 29. [Parenthetically, it is most certainly true that COVID-19 deaths occurred before the first recognized case in Washington State on that date, but that is not our focus here.] The figure shows the overall shape of the mortality profile over time on the log scale. Notice how the vertical axis goes up non-linearly. In a typical epidemic, the cumulative event count curves up at first, shifts to a straight diagonal incline during a period of exponential growth, then slows down to a gentle rate of rise before flattening as the rate of new events slows and eventually stops. On the log scale, these shifts look more pronounced. It is just a scaling adjustment, the underlying data are not affected. I have superimposed on the figure some markers for the doubling times, when cumulative numbers increased by a factor of two. The doubling times are a useful tool for gauging the speed of the epidemic. In Figure F, it’s very hard to see first phase when deaths are ramping up. However, the period of exponential growth in deaths is clearly visible as a straight diagonal line (on the log scale) from early March (25 deaths) to early April (8,300 deaths), when the doubling time was less than a week. The slow down phase is evident from then to May 12 when doubling times fell first to 10 days and then 22 days; meanwhile we hit the 75,000 death marker. The next doubling took 91 days (August 11, 152,000 deaths). The good news is that exponential growth in deaths was clearly over and past us. The bad news is that the outbreak didn’t die out (so to speak). The curve never fully flattens. Importantly, on the log scale, it is very hard to see the details of what actually happened over the summer. It looks like things were better but not ideal because the curve keeps rising. Figure F doesn’t help us explain the summer hump clearly visible in Figure E. For that we need to change perspectives. Shift now to the bottom graph (Figure G), which shows cumulative deaths on the linear scale. It’s the same data, but expressed in a different metric – kind of like looking at the same external world through lenses of a different color. Our attention and our eyes are drawn to different features based on the shape of the data in this perspective. Instead of doubling times, I show you the interval (in days) between each successive 25,000 deaths. The start of the epidemic is in sharper relief here, as we can more clearly see the gradual ramp up. Even though doubling rates were rapid due to exponential growth, it actually took us 47 days to accumulate the first 25,000 deaths. In the next 50 days (from April 14 to June 3) we added 75,000 more. The interval from 100 to 125K was slower at 41 days. But since mid-July, the interval dropped to 25 and then 26 days. That is where the summer hump happened. What does it mean: The two ways of looking at deaths are neither right nor wrong, but they are different. On the log scale, we can take some comfort in the fact that we are clearly no longer in the explosive exponential growth in deaths we saw in March and April. On the other hand, the epidemic curve never flattened this summer. And the log scale doesn’t do a good job of illuminating the backsliding we actually did over the summer, when deaths began to accelerate again. All of this of course is a prelude for the immanent arrival of cold weather and the unfolding of additional waves of infectious respiratory disease outbreaks that will no doubt complicate the picture moving forward.
Politics article by Joe Pinsker, online at The Atlantic , September 16, 2020.
Do you, like me, find yourself fantasizing about what you will do when all this is over? You are not alone. For me, it’s movies in the cinema and live music in small venues. The reality is that we may not find a clear and discernible end. Instead, SARS-CoV-2 is likely to become, like influenza, a permanent fixture of our ecology. As the Columbia epidemiologist Stephen Morse says (from the article) “You can’t sign a treaty with a virus, so we have to settle for a kind of cease-fire…” This article covers some of the psychological and cultural aspects of this unfolding pandemic and gently walks us toward a more realistic set of expectations.
Today’s bite-sized, handpicked selection of important news, information or science for all who want to know where this epidemic is going and what we should do.
CDC director Dr. Robert Redfield predicted today that most of the American public will not have access to a coronavirus vaccine until at least late spring or summer of next year. This prompted strong rebuke from President Trump who said he was wrong. Virtually all experts agree with Director Redfield and most think that’s even optimistic. Since we do not yet have any vaccine that has proven to be effective, talking about any timelines is putting the cart before the horse. (Washington Post)
UK scientists are testing whether COVID-19 vaccines might work better if inhaled vs. injected. A small study using the Imperial and Oxford vaccine is underway. Previous influenza studies have shown that sending the vaccine directly to the airway can improve response. (AP News)
Urban hospitals serving poor and working class communities like Mercy Hospital & Medical Center in Chicago are joining the ranks of many smaller rural community hospital as endangered species, as COVID-19 adds to financial strains for underfunded centers of care (NPR)
President Trump’s top communication aide in charge of coronavirus response Michael R. Caputo told news outlets this week that the CDC was harboring a “resistance unit” determined to undermine the President and (without evidence) that left-wing hit squads were threatening armed insurrection after the election and out to get him. Somebody needs a time out! (New York Times)
Researchers at Duke looked at the link between socioeconomic disadvantage, red/blue politics, and change in COVID-19 cases in U.S. counties throughout June. They found that counties with a big city, more social deprivation and that voted for Trump in 2016, all had significantly faster growth in new cases. This suggests that republican policies at the state and local level may be less effective at stopping the spread of coronavirus. (Clinical Infectious Disease)
We already knew that the broad-spectrum anti-viral drug Remdesivir (brand name Veklury) improved outcomes in severe COVID-19 patients. A new study looked at this question in moderately sick patients. The results are complicated, or (in my opinion) borderline. There was a small but significant benefit for a 5-day course of treatment, but no slam-dunk improvement after a 10-day course. It’s very positive however that we are now able to dig into the details of what works and does not. (JAMA)
Powerful study of nursing home residents in Connecticut shows a higher percentage of asymptomatic infections than we thought. Why does this matter? Many have assumed that the most vulnerable groups (very old people living in nursing homes) would be less likely than younger people to have inapparent infections. For that reason, nursing home residents with no symptoms were often not tested. A survey of CT nursing homes in May found that more than 600 residents (or 28%) were positive. Importantly, 88% of positive cases were entirely asymptomatic when tested. Inapparent infections are key to understanding and controlling the risks for our most vulnerable citizens. (JAMA)
Once again, it looks like U.S. cases are finally. Here’s why I don’t believe it Through most of the last week, it looked like the U.S. case numbers had resumed their steady decline. Numerous commentators have spoken of infection rates that are finally coming down (See Figure A). Not so fast. First of all, you will notice an upward hook in the 7-day moving average. It’s not caused by a dramatic uptick on Monday and Tuesday, but rather, by the big dip on September 7-8. But there is a bigger reason. Have a look at Figure B. I found out how to recreate a graph I was making myself for a few months using the 91-divoc site and data from Our World in Data. Three cheers to both those groups! The darker blue line shows COVID-19 tests per day (Figure B). I have highlighted September 3, when the U.S. was averaging 860,000 tests a day or 260 per 100,000 people. That rate was significantly below the U.S. peak, which occurred on July 22, topping out at just over a million tests a day. Look at the last 2 weeks. As of today, the U.S. has plummeted to an average of 503,000 tests or 152 per 100,000. That is a 30% drop in testing capacity in just 2 weeks (35% since the July peak). Gee, I wonder why testing is dropping faster than the leaves on the trees? Test positivity has inched down slightly but remains above 6% and appears to be spiking upward in the last couple of days (thinner blue line). It certainly isn’t going down enough to warrant taking our foot off the testing accelerator. The bottom line: The sneaky way to slow an epidemic is to slow how much you test for the disease. If you cut out a third of the testing, you will make it look like there are a third fewer cases even when transmission intensity is holding steady. That’s why I don’t believe the story the daily case totals are telling us now. Next time, I will dig into the states that are cutting testing the most. Any guesses?
U.S. daily deaths holding steady for now, rising in some surprising places After a fairly quiet weekend, U.S. daily COVID-19 deaths spiked again to over 1,000 on Tuesday as the total number of fatalities from lab-confirmed COVID-19 approaches 200,000 (See Figure C). A look at the state numbers reveals some surprises. Compared to two weeks ago, deaths nearly tripled in Washington state (+182%) with the addition of 62 reported fatalities. In the West, deaths were also on the rise in Idaho (+62%), and Oregon (+57%). In the Midwest, deaths rose in all states except Missouri, and going through the roof in Nebraska (+314%). Sizable weekly increases were also reported in Alabama (+96%), Florida (+61%), Kentucky (+57%), Mississippi (+62%), Tennessee (+101%) and Virginia (+86%). The bottom line: Deaths and hospitalizations are up in several states in all regions. Thankfully, deaths are falling in Arizona, Missouri and Texas, which helps to mitigate severity of the overall picture.
Quirky Qorner: What Are The New Dating Rules? And, is sex with masks a thing? Not sure about you, but my love life is going great guns right now. NOT! Admit it, the question on everyone’s mind: when can we start dating again? That’s why an article by Isabella Gomez Sarmiento at NPR.org caught my eye this week. If nothing else, the cartoon under the headline is worth our time. Among the hot topics discussed in this article: Are sex with masks really a thing? You’ll have to read it for the answer.